ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Dressing membrane composites of PVA/chitosan/MgO nanoparticles for wound healing applications in rat model.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitosan (CS) has excellent film-forming properties; unfortunately, its use as a film wound dressing is limited because of its weak mechanical properties, especially in its wet state. For this reason, modifications with different materials are investigated in this study. The aim of this work was the combination of chitosan with poly (vinyl alcohol) (PVA), magnesium oxide nanoparticles (MgO), and glycerol as a plasticizer agent which can strengthen CS films, increase their flexibility, and enhance their resistance to microbes. Four types of films were prepared, i.e., CS, PVA, CS/PVA, and CS/PVA@MgO, using solvent casting method. The films' ability for wound dressing was assessed by UV spectroscopy, mechanical properties, Fourier transform infrared, X-ray diffraction, antimicrobial activity, and in vivo studies as a practical application on wounds. CS/PVA@MgO showed an improvement in mechanical properties as it has elongation at break of 522% and strain 585%. In addition, the antimicrobial activity of CS/PVA@MgO film was extensively enhanced as it inhibited Escherichia coli, Staphylococcus aureus, and Candida albicans by 90.78%, 88.83%, and 97.18%, respectively. The results showed that composite film has a good mechanical properties and antimicrobial activity expressed a suitable wound dressing material. Furthermore, in vivo experiment evaluated the clinical efficacy of CS/PVA@MgO film in wound healing.
Indexed as
Identifiers
39704805What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.